Navigation Links
Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint

-- Data from Serial Outpatient Infusion Study in Patients with Chronic Decompensated Heart Failure Presented at the American College of Cardiology 56th Annual Scientific Session --

MOUNTAIN VIEW, Calif. and NEW ORLEANS, March 25, 2007 /PRNewswire/ -- Scios Inc. announced today that an exploratory, 920-patient, Phase 2 study of nesiritide (NATRECOR(R)) showed a neutral effect on the primary endpoint, a composite of death and cardiorenal hospitalization at 12 weeks, and provides important renal and mortality safety data on nesiritide in patients with advanced chronic decompensated heart failure (CDHF) receiving serial outpatient infusions.

Data from the study, known as FUSION II (Follow-Up Serial InfusiOns of NATRECOR(R) in Advanced Heart Failure), were presented during a late-breaking clinical trial session at the of Cardiology's 56th Annual Scientific Session in New Orleans (presentation #402-9). Scios also announced that it plans to submit the safety data from this and other recent trials to the U.S. Food and Drug Administration (FDA).

NATRECOR(R) is the only FDA-approved intravenous treatment for patients with acutely decompensated congestive heart failure (ADHF) who have dyspnea (shortness of breath) at rest or with minimal activity.

FUSION II was designed to assess the long-term safety and outcomes at six months of once- or twice-weekly infusions of nesiritide compared to placebo in persistently symptomatic CDHF patients. All patients received ongoing intensive heart failure disease management, including optimization of standard heart failure medications and once or twice weekly outpatient clinic visits. Patients who participated in this trial had to have two prior recent hospitalizations, either NYHA class III or IV heart failure and had to have been out of the hospital for at least five days prior to enrollment in the trial.

The study demonstrated comparable renal and mortality
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:8/29/2014)... , Aug. 29, 2014 Pomerantz LLP ... S.A. ("EDAP" or the "Company") (NASDAQ: EDAP ) ... in United States District Court, Southern District of ... is on behalf of a class consisting of all ... 1, 2013 and July 30, 2014, inclusive (the "Class ...
(Date:8/29/2014)... 29, 2014   Mast Therapeutics, Inc. ... today that Santosh Vetticaden, Chief Medical Officer and ... for personal reasons, in mid-September.  Edwin L. ... Aires Pharmaceuticals, which Mast acquired earlier this year, ... Company,s interim Chief Medical Officer.  Dr. Parsley previously ...
(Date:8/29/2014)... -- Thoratec Corporation (NASDAQ: THOR ), a ... save, support and restore failing hearts, said today it ... Healthcare Conference on Wednesday, September 10. ... will provide an update on the company, beginning at ... Time).   A webcast of the presentation ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4
... Oct. 15 VWR International, LLC today celebrates the official ... Corporate Center in Radnor, PA. The new facility not only ... the opportunity for increased staffing as the company grows. ... supply and distribution companies, with worldwide sales in excess of ...
... The Pharmacy Technician Certification Board (PTCB) is proud to ... Pharmacy Seminar (JFPS) in Chattanooga, Tenn., October 18–21, 2010. ... Navy, Air Force and Coast Guard pharmacy community. Pharmacists ... retired communities, as well as civilian pharmacists and technicians ...
Cached Medicine Technology:VWR Opens New Global Headquarters in Radnor, PA 2VWR Opens New Global Headquarters in Radnor, PA 3PTCB Sponsors Joint Forces Pharmacy Seminar Challenge Coin 2
(Date:8/31/2014)... Richmond, CA (PRWEB) August 31, 2014 ... program of the California State Library, celebrates 30 ... and their families. Since its inception, California’s Library ... a million Californians learn to read and write. ... this volunteer-based program, the state is launching a ...
(Date:8/31/2014)... 2014 The severity of menopausal symptoms ... in menopause is expert in helping patients find ... from uncomfortable symptoms with the latest treatment options, including ... a variety of alternative treatments and products that can ... options may fall outside of what can be called ...
(Date:8/31/2014)... Spain Sunday 31 August 2014: Drinking tea reduces ... 000 people presented at ESC Congress today by Professor ... you have to choose between tea or coffee it,s ... important components of our way of life. Their effects ... past with sometimes divergent results. We investigated the effects ...
(Date:8/30/2014)... 2014: Local anaesthetic is as safe and effective for ... to results of the FRANCE 2 registry presented at ... , Dr Chopard said: "Numerous studies have shown that ... severe symptomatic aortic stenosis who are at very high ... The number of TAVI procedures in France and around ...
(Date:8/30/2014)... Orlando, Florida (PRWEB) August 31, 2014 ... gait walking and how a mobility device can help in ... now available for free download from the website that contains ... medical doctor for this site. , The articles deal with ... mobility device like a walking cane can help in making ...
Breaking Medicine News(10 mins):Health News:California Library Literacy Services Celebrates 30th Anniversary 2Health News:California Library Literacy Services Celebrates 30th Anniversary 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 2Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 4Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 5Health News:Drinking tea reduces non-CV mortality by 24 percent 2Health News:Drinking tea reduces non-CV mortality by 24 percent 3Health News:Local anesthetic for TAVI as safe and effective as general anesthetic 2Health News:Information Articles on Gait Problems from Walking-Canes.Net 2
... of Medicine (IOM) recently released a study, The Future ... calls for new and expanded roles for nurses in ... education for all nurses and allowing nurses to practice ... It advocates overhauling state scope of practice acts and ...
... was diagnosed in 2007 with acute multiple myeloma, a form ... troubles all those who receive an upsetting diagnosis. The way ... however, was different. Barrager drew upon his engineering and management ... is sharing his insights with hospitals and doctors in his ...
... Steven Reinberg HealthDay Reporter , MONDAY, Nov. ... pandemic H1N1 flu last year in California, more than ... California Department of Public Health researchers report. , ... to occur at similar rates as with seasonal influenza, ...
... News) -- Military veterans with psychiatric illnesses are at ... The greatest risk is among males with bipolar disorder ... researchers at the U.S. Department of Veterans Affairs and ... Overall, bipolar disorder (the least common diagnosis at 9 ...
... , MONDAY, Nov. 1 (HealthDay News) -- Any ... removed from play until evaluated by a physician who ... a new position statement issued by the American Academy ... recommendations directed at policymakers who develop procedures to be ...
... MONDAY, Nov. 1 (HealthDay News) -- Stroke patients are more ... the weekend instead of a weekday, regardless of the severity ... analyzed data from almost 21,000 stroke patients admitted to 11 ... their first stroke were included in the study. Seven ...
Cached Medicine News:Health News:ACP's response to the IOM's report the future of nursing: Leading change, advancing health 2Health News:ACP's response to the IOM's report the future of nursing: Leading change, advancing health 3Health News:ACP's response to the IOM's report the future of nursing: Leading change, advancing health 4Health News:ACP's response to the IOM's report the future of nursing: Leading change, advancing health 5Health News:ACP's response to the IOM's report the future of nursing: Leading change, advancing health 6Health News:Management science guru, surviving cancer, offers hope to fellow sufferers, doctors 2Health News:Management science guru, surviving cancer, offers hope to fellow sufferers, doctors 3Health News: Pandemic H1N1 Flu Hit Kids Hard in 2009 2Health News: Pandemic H1N1 Flu Hit Kids Hard in 2009 3Health News:Bipolar Disorder Tied to High Suicide Risk in Veterans 2Health News:Concussion Should Sideline Athletes: Neurologists 2Health News:Weekend Admissions Worse for Stroke Victims: Study 2
... Compact and durable, the Medelec ... Whether your choice of a smaller ... your need to take your testing ... Notebook is the solution. The 2, ...
The Nicolet Bravo is a Multi-application system that can configure to meet the needs of neurophysiology deparent....
... Myoquick 1200/1400/1800 units are based ... adopt the ISA 100x EP ... can select input units with ... 1002 EP), 4 channels (ISA ...
Sierra II power & efficiency plus. Sierra II report generator with automatic sentence generation creates the one-minute report. Complete 2/4 channel EMG/NCV/EP....
Medicine Products: